Lyophilized IVIG - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240632

Publication Date:

September 24, 2024

Pages:

120

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Intravenous immunoglobulin听(IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors.
The global market for Lyophilized IVIG was estimated to be worth US$ 145 million in 2023 and is forecast to a readjusted size of US$ 246.4 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lyophilized IVIG, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lyophilized IVIG by region & country, by Type, and by Application.
The Lyophilized IVIG market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized IVIG.
麻豆原创 Segmentation
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type:
2.5g
1.25g
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lyophilized IVIG in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Lyophilized IVIG Product Introduction
1.2 Global Lyophilized IVIG 麻豆原创 Size Forecast
1.2.1 Global Lyophilized IVIG Sales Value (2019-2030)
1.2.2 Global Lyophilized IVIG Sales Volume (2019-2030)
1.2.3 Global Lyophilized IVIG Sales Price (2019-2030)
1.3 Lyophilized IVIG 麻豆原创 Trends & Drivers
1.3.1 Lyophilized IVIG Industry Trends
1.3.2 Lyophilized IVIG 麻豆原创 Drivers & Opportunity
1.3.3 Lyophilized IVIG 麻豆原创 Challenges
1.3.4 Lyophilized IVIG 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lyophilized IVIG Players Revenue Ranking (2023)
2.2 Global Lyophilized IVIG Revenue by Company (2019-2024)
2.3 Global Lyophilized IVIG Players Sales Volume Ranking (2023)
2.4 Global Lyophilized IVIG Sales Volume by Company Players (2019-2024)
2.5 Global Lyophilized IVIG Average Price by Company (2019-2024)
2.6 Key Manufacturers Lyophilized IVIG Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lyophilized IVIG Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lyophilized IVIG
2.9 Lyophilized IVIG 麻豆原创 Competitive Analysis
2.9.1 Lyophilized IVIG 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lyophilized IVIG Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized IVIG as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 2.5g
3.1.2 1.25g
3.2 Global Lyophilized IVIG Sales Value by Type
3.2.1 Global Lyophilized IVIG Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lyophilized IVIG Sales Value, by Type (2019-2030)
3.2.3 Global Lyophilized IVIG Sales Value, by Type (%) (2019-2030)
3.3 Global Lyophilized IVIG Sales Volume by Type
3.3.1 Global Lyophilized IVIG Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lyophilized IVIG Sales Volume, by Type (2019-2030)
3.3.3 Global Lyophilized IVIG Sales Volume, by Type (%) (2019-2030)
3.4 Global Lyophilized IVIG Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Lyophilized IVIG Sales Value by Application
4.2.1 Global Lyophilized IVIG Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lyophilized IVIG Sales Value, by Application (2019-2030)
4.2.3 Global Lyophilized IVIG Sales Value, by Application (%) (2019-2030)
4.3 Global Lyophilized IVIG Sales Volume by Application
4.3.1 Global Lyophilized IVIG Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lyophilized IVIG Sales Volume, by Application (2019-2030)
4.3.3 Global Lyophilized IVIG Sales Volume, by Application (%) (2019-2030)
4.4 Global Lyophilized IVIG Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lyophilized IVIG Sales Value by Region
5.1.1 Global Lyophilized IVIG Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lyophilized IVIG Sales Value by Region (2019-2024)
5.1.3 Global Lyophilized IVIG Sales Value by Region (2025-2030)
5.1.4 Global Lyophilized IVIG Sales Value by Region (%), (2019-2030)
5.2 Global Lyophilized IVIG Sales Volume by Region
5.2.1 Global Lyophilized IVIG Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lyophilized IVIG Sales Volume by Region (2019-2024)
5.2.3 Global Lyophilized IVIG Sales Volume by Region (2025-2030)
5.2.4 Global Lyophilized IVIG Sales Volume by Region (%), (2019-2030)
5.3 Global Lyophilized IVIG Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lyophilized IVIG Sales Value, 2019-2030
5.4.2 North America Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lyophilized IVIG Sales Value, 2019-2030
5.5.2 Europe Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lyophilized IVIG Sales Value, 2019-2030
5.6.2 Asia Pacific Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lyophilized IVIG Sales Value, 2019-2030
5.7.2 South America Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lyophilized IVIG Sales Value, 2019-2030
5.8.2 Middle East & Africa Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lyophilized IVIG Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lyophilized IVIG Sales Value
6.2.1 Key Countries/Regions Lyophilized IVIG Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lyophilized IVIG Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lyophilized IVIG Sales Value, 2019-2030
6.3.2 United States Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lyophilized IVIG Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lyophilized IVIG Sales Value, 2019-2030
6.4.2 Europe Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lyophilized IVIG Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lyophilized IVIG Sales Value, 2019-2030
6.5.2 China Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lyophilized IVIG Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lyophilized IVIG Sales Value, 2019-2030
6.6.2 Japan Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lyophilized IVIG Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lyophilized IVIG Sales Value, 2019-2030
6.7.2 South Korea Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lyophilized IVIG Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lyophilized IVIG Sales Value, 2019-2030
6.8.2 Southeast Asia Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lyophilized IVIG Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lyophilized IVIG Sales Value, 2019-2030
6.9.2 India Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lyophilized IVIG Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Lyophilized IVIG Product Offerings
7.1.5 Takeda Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Introduction and Business Overview
7.2.3 Grifols Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Grifols Lyophilized IVIG Product Offerings
7.2.5 Grifols Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Introduction and Business Overview
7.3.3 CSL Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CSL Lyophilized IVIG Product Offerings
7.3.5 CSL Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Octapharma Lyophilized IVIG Product Offerings
7.4.5 Octapharma Recent Development
7.5 Biotest
7.5.1 Biotest Company Information
7.5.2 Biotest Introduction and Business Overview
7.5.3 Biotest Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biotest Lyophilized IVIG Product Offerings
7.5.5 Biotest Recent Development
7.6 Kedrion
7.6.1 Kedrion Company Information
7.6.2 Kedrion Introduction and Business Overview
7.6.3 Kedrion Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kedrion Lyophilized IVIG Product Offerings
7.6.5 Kedrion Recent Development
7.7 Hualan Bio
7.7.1 Hualan Bio Company Information
7.7.2 Hualan Bio Introduction and Business Overview
7.7.3 Hualan Bio Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hualan Bio Lyophilized IVIG Product Offerings
7.7.5 Hualan Bio Recent Development
7.8 CNBG
7.8.1 CNBG Company Information
7.8.2 CNBG Introduction and Business Overview
7.8.3 CNBG Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.8.4 CNBG Lyophilized IVIG Product Offerings
7.8.5 CNBG Recent Development
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Information
7.9.2 Shanghai RAAS Introduction and Business Overview
7.9.3 Shanghai RAAS Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Shanghai RAAS Lyophilized IVIG Product Offerings
7.9.5 Shanghai RAAS Recent Development
7.10 CBPO
7.10.1 CBPO Company Information
7.10.2 CBPO Introduction and Business Overview
7.10.3 CBPO Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.10.4 CBPO Lyophilized IVIG Product Offerings
7.10.5 CBPO Recent Development
7.11 LFB Group
7.11.1 LFB Group Company Information
7.11.2 LFB Group Introduction and Business Overview
7.11.3 LFB Group Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.11.4 LFB Group Lyophilized IVIG Product Offerings
7.11.5 LFB Group Recent Development
7.12 BPL
7.12.1 BPL Company Information
7.12.2 BPL Introduction and Business Overview
7.12.3 BPL Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.12.4 BPL Lyophilized IVIG Product Offerings
7.12.5 BPL Recent Development
7.13 Sichuan Yuanda Shuyang
7.13.1 Sichuan Yuanda Shuyang Company Information
7.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview
7.13.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Sichuan Yuanda Shuyang Lyophilized IVIG Product Offerings
7.13.5 Sichuan Yuanda Shuyang Recent Development
8 Industry Chain Analysis
8.1 Lyophilized IVIG Industrial Chain
8.2 Lyophilized IVIG Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lyophilized IVIG Sales Model
8.5.2 Sales Channel
8.5.3 Lyophilized IVIG Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.